Well, this was filed on June 3, 2022 and indicates that Denner had been in discussion with Amarin’s management before then:
“The Reporting Persons have had discussions with the Issuer and other interested parties about ways to maximize the value of the Issuer’s assets. More recently, the Reporting Persons discussed with the Issuer the disappointing first quarter results. The Reporting Persons believe that the meaningful decrease in Share price following the earnings announcement reflects the Issuer’s insufficient adjustment to changing market conditions for its key drug Vascepa and investor concerns about the ability of leadership as currently constituted to navigate the Issuer during this critical time. The Reporting Persons believe that the expertise and experience of its principals would be extremely beneficial to the Issuer and intend to seek representation on the Issuer’s board of directors. The Reporting Persons believe the Shares continue to be significantly undervalued. The Reporting Persons thank the many shareholders who have reached out to them seeking guidance on how to vote at the Issuer’s upcoming annual meeting. The Reporting Persons will disclose their intentions with respect to the Issuer’s upcoming annual meeting, including how they intend to vote their shares, following the outcome of the ongoing discussions with the Issuer. The Reporting Persons will continue to review their investment on an ongoing basis and reserve the right to, from time to time and at any time: (i) acquire additional Securities of the Issuer in the open market or otherwise; (ii) dispose of any or all of their Securities in the open market or otherwise; or (iii) engage in any hedging or similar transactions with respect to the Securities.”
So, Sarissa did act last year. They gave management time to course correct and also it takes time to get all the ducks in a row to go forward with the special meeting. Would you just go through the hassle of calling a special meeting without any preparation. It shows Sarissa thinks about what they are doing and prepares.
I assume he didn’t act last year because he was still building his position and likely didn’t think he’d have enough shares behind him.
I really don’t get all these people who are fine waiting around another 3-5 years. You do realize this is a one drug company with their runway shortening every passing day? All while management has acted as though it’s their personal piggy bank. Cashing free shares for millions at every turn. Never, ever putting their own money on the line.
And spare me with the BOD turnover. They were hand picked replacements by the old guard. Basically more of the same and their resumes aren’t impressive in the slightest.
It’s Denner and BO or watch the company circle the drain attempting to GIA. It’s really simple.
It takes time to build a collation of 67% of the shareholders. Until recently our albatross around our necks was Baker Bro's. They had 10's of millions of shares not friendly to Denner's attempt. I'm convinced that Dr. Denner has that collation now.